Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: Implications for the treatment of tardive dyskinesia
- 1 June 1975
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 31 (6), 669-671
- https://doi.org/10.1007/bf01944619
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Short- and long-term regulation of tyrosine hydroxylase.1974
- Therapeutic Approaches to Tardive DyskinesiaArchives of General Psychiatry, 1972
- Potentiation of phenothiazines by?-methyltyrosine in treatment of chronic schizophreniaJournal of Neural Transmission, 1972
- Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- The dyskenesias: a new therapeutic approach.1971
- Effect of decarboxylase inhibition and neuroleptic drugs on the DOPA level in rat brain.1970
- Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analoguesEuropean Journal of Pharmacology, 1970
- The mono-amine oxidase inhibitors; their usefulness and their safety.1969
- A sensitive and specific assay for the estimation of monoamine oxidaseBiochemical Pharmacology, 1963
- A Fluorimetric Method for the Determination of Dopamine (3‐Hydroxytyramine.)Acta Physiologica Scandinavica, 1958